Metraipolis › archive › dc_d540cade51da

TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention — Europe PMC PMID:42602355

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42602355
DOI
10.3389/fimmu.2026.1893545
License (as archived)
solo-consultazione
Archived
2026-10-17T06:43:29.557Z
SHA-256 of the archived text
4ed9ea87177b9856e9515db8b1e9e51ee84cb43d1d78743ddbea43165894788e
Stable URL of this page
https://metraipolis.com/documento/dc_d540cade51da

How to cite

TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention — Europe PMC PMID:42602355 — Europe PMC (en), https://europepmc.org/article/MED/42602355 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d540cade51da (Metraipolis archive dc_d540cade51da, sha256 4ed9ea87177b9856e9515db8b1e9e51ee84cb43d1d78743ddbea43165894788e)
BibTeX
@misc{dcd540cade51da,
  title = {TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention — Europe PMC PMID:42602355},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42602355},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d540cade51da; sha256 4ed9ea87177b9856e9515db8b1e9e51ee84cb43d1d78743ddbea43165894788e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602355. Agents can read the archived copy with the MCP tool read_document.